Merit Medical Announces Acquisition Of Dialysis Catheter Portfolio And The Biosentry® Biopsy Tract Sealant System From Angiodynamics, Inc. And Acquisition Of The Surfacer® Inside-Out® Access Catheter System From Bluegrass Vascular Technologies, Inc.
Jun 08, 2023•over 2 years ago
Acquiring Company
Merit
Acquired Company
Dialysis Catheter Portfolio
Description
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced it has completed the acquisition of a portfolio of dialysis catheter products and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. for a total cash consideration of $100 million. Merit also announced the recent acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc. for a total cash consideration of $32.5 million.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed